Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
Medicare (CMS) July 8th 2018 Local Coverage Determination (LCD) Updates
Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »
July 8th 2018 LCD Updates:
- L33392 Category III CPT® Codes
- A54314 Controlled Substance Monitoring and Drugs of Abuse Coding and Billing Guidelines
- L36029 Controlled Substance Monitoring and Drugs of Abuse Testing
- A52408 Filgrastim, Pegfilgrastim, Tbo-filgrastim, Filgrastim-sndz (e.g., Neupogen®, Neulasta ™, Granix ™ Zarxio™) – Related to LCD L33394
- L35427 Hyaluronan Acid Therapies for Osteoarthritis of the Knee
- L35448 Independent Diagnostic Testing Facility (IDTF)
- L35677 Infliximab
- L34220 Lumbar MRI
- L37281 Lumbar MRI
- A55711 MolDX: Abbott RealTime IDH2 testing for Acute Myeloid Leukemia (AML) Billing and Coding Guidelines
- A55712 MolDX: Abbott RealTime IDH2 testing for Acute Myeloid Leukemia (AML) Billing and Coding Guidelines
- A55881 MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer Billing and Coding Guidelines
- A55888 MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer Billing and Coding Guidelines
- L36139 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36082 MolDX: BRCA1 and BRCA2 Genetic Testing
- L36458 MolDX: Breast Cancer Index℠ Genetic Assay
- A54878 MolDX: CDH1 Genetic Testing Coding and Billing Guidelines
- L36117 MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
- L35984 MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L37699 MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
- L35160 MolDX: Molecular Diagnostic Tests (MDT)
- L36256 MolDX: Molecular Diagnostic Tests (MDT)
- L36011 MolDX: Molecular RBC Phenotyping
- A55294 MolDX: Myriad’s BRACAnalysis CDx™ Billing and Coding Guidelines
- A55295 MolDX: Myriad’s BRACAnalysis CDx™ Billing and Coding Guidelines
- A54689 MolDX: Myriad’s BRACAnalysis CDx™ Coding and Billing Guidelines
- L36174 MolDX: NSCLC, Comprehensive Genomic Profile Testing
- L35000 Molecular Pathology Procedures
- L35451 Non-Invasive Peripheral Venous Studies
- L33628 Panretinal (Scatter) Laser Photocoagulation
- L34430 Respiratory Therapy (Respiratory Care)
- A56017 Response to Comments: Lumbar MRI
- A56018 Response to Comments: Lumbar MRI
- A56038 Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
- A55982 Response to Comments: Molecular Pathology Procedures
- A52452 Rituximab (Rituxan®) – Related to LCD L33394
- L33454 Varicose Veins of the Lower Extremities
Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.